This Week on NeurologyLive — November 23, 2020

November 23, 2020
NeurologyLive Staff

Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.

The third segment of the "Updates in the Management of Relapsing Multiple Sclerosis" Peer Exchange premieres Monday, November 23, 2020, and focuses on the misdiagnosis of multiple sclerosis. The panelists discussed their clinical workup criteria, including the use of cerebrospinal fluid, to make a more accurate multiple sclerosis diagnosis. They also touch on the importance of misdiagnosis and how it can impact patients if they are recommended the wrong treatments.

To catch up on the rest of the series, click here.

Also going live on Tuesday is a piece from our October 2020 special issue titled, "The Future of Multiple Sclerosis Imaging," authored by Pascal Sati, PhD, director, Neuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center. Sati discussed how advanced imaging technology is on a collision course with artificial intelligence, and how that intersection is shaping up to be a revolutionary period for the diagnosis and management of MS.

For more of our print issues, click here.

On Wednesday, November 25, 2020, the latest edition of our NeuroVoices series goes live, this time featuring Michael S. Okun, MD, executive director, Norman Fixel Institute for Neurological Diseases, University of Florida. Okun sat down to discuss his recently published editorial on reforming the process for deep brain stimulation and neurologic device approval in rare diseases. Specifically, he covers the barriers placed by insurance companies, recommendations for more disease-based registries, and his call to action for what needs to change.

To check out the prior NeuroVoices conversations, click here.

A conversation with Steven Arnold, MD, professor of neurology, Harvard Medical School, and managing director, Interdisciplinary Brain Center, Massachusetts General Hospital, will air on NeurologyLive's segment on the Medical World News channel this Thursday, November 26, 2020. Arnold discussed the latest on the ongoing phase 2 PEGASUS trial of AMX0035 in Alzheimer disease.

To check out the Medical World News channel, click here.